Breast screening

Will ductal carcinoma in situ defeat breast cancer screening?

BMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b957 (Published 9 March 2009)
Cite this as: BMJ 2009;338:b957

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. John R Benson, consultant breast surgeon1
  1. 1Addenbrooke’s Hospital, Cambridge CB2 0QQ
  1. john.benson{at}addenbrookes.nhs.uk

    Gøtzsche and colleagues focus on the inadequacy of patient information leaflets in the NHS breast screening programme.1

    The failure to disclose information on ductal carcinoma in situ has aptly been described by a patient representative as a “closely guarded state secret.” Ductal carcinoma in situ constitutes up to a fifth of …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL